JMIR Publications

ABSTRACT

Background:

Artificial intelligence (AI) has become one of the most transformative forces in modern medicine, promising enhanced diagnostic accuracy, predictive analytics, and greater operational efficiency across clinical settings. However, despite remarkable technical progress, translating AI systems from pilot projects to sustainable clinical use has been inconsistent. Many implementations remain confined to prototypes or local trials, while evidence about long-term value and equity is fragmented. The Quadruple Aim, improving patient experience, population health, cost efficiency, and provider well-being, offers a comprehensive framework for assessing whether AI truly advances the mission of value-based care.

Objective:

This systematic review synthesizes evidence from 34 peer-reviewed publications (2019–2026) to identify key challenges and opportunities in implementing AI tools in healthcare and to interpret findings through the Quadruple Aim framework.

Methods:

In accordance with PRISMA 2020 guidelines, a systematic search was conducted across PubMed, Scopus, and Web of Science. The initial search yielded 652 records. After removing 277 duplicates, 375 unique studies were screened by title and abstract, of which 283 were excluded for failing to meet the inclusion criteria. Following full-text assessment, 34 studies met all inclusion criteria. Data were extracted using a structured framework and synthesized thematically. Findings were mapped onto the four dimensions of the Quadruple Aim.

Results:

Of the 34 included studies, the most prevalent implementation barriers were workflow disruption and usability challenges (74%), trust and explainability limitations (71%), data quality and interoperability failures (68%), clinician knowledge and training gaps (62%), and regulatory uncertainty (53%). Key opportunities included predictive analytics and early warning systems (56%), stakeholder engagement and co-design (53%), workflow optimization and automation (50%), and patient engagement and access (44%). Mapping findings to the Quadruple Aim revealed that 23 studies addressed provider well-being, 22 addressed cost and system efficiency, 21 addressed patient experience, and 20 addressed population health.

Conclusions:

Evidence from 34 peer-reviewed publications underscores both optimism and caution regarding AI’s role in healthcare. While most studies confirm AI’s potential to enhance quality, safety, and efficiency, barriers related to governance, transparency, workforce readiness, and equitable design continue to impede scale-up. Sustainable success requires aligning AI strategies with the Quadruple Aim through robust data governance, inclusive co-design, investment in digital-health literacy, and rigorous economic evaluation.